Evidence map›Paper›PMID 38225226›Full record

ArticleNature communications2024

Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration.

Yu-Jung Tseng, Yuki Kageyama, Rebecca L Murdaugh, Ayumi Kitano, Jong Hwan Kim, Kevin A Hoegenauer, Jonathan Tiessen, Mackenzie H Smith, Hidetaka Uryu, Koichi Takahashi and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Molecular and therapeutic frontiers in anemia therapy.The Journal of clinical investigation · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yu-Jung Tseng *Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID 0000-0002-9537-2493
Yuki Kageyama *Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Rebecca L MurdaughGraduate Program in Developmental Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Ayumi KitanoDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Jong Hwan KimDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX, 77030, USA.
Kevin A HoegenauerDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Jonathan TiessenGraduate Program in Developmental Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Mackenzie H SmithDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Hidetaka UryuDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID 0000-0001-7167-895X
Koichi TakahashiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.ORCID 0000-0002-8027-9659
James F MartinDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID 0000-0002-7842-9857
Md Abul Hassan SameeDepartment of Integrative Physiology, Baylor College of Medicine, Houston, TX, 77030, USA.ORCID 0000-0002-7472-1156
Daisuke NakadaGraduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, 77030, USA. nakada@bcm.edu.ORCID 0000-0001-6010-7094

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
University of Texas M.D. Anderson Cancer SPORE-LeukemiaP50CA100632 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KONOPLEVA, MARINA Y · 2003 to 2023
$43.7M
Project 3: Contribution of inflammation and DNA damaging factors to clonal expansion and malignant transformation in a community cohort of older adultsP01CA265748 · NCI · BAYLOR COLLEGE OF MEDICINE · PI Daisuke Nakada · 2022 to 2026
$13.6M
Training In Cell and Gene TherapyT32HL092332 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MALCOLM K. BRENNER, Bruno Di Stefano · 2008 to 2026
$6.9M
Pitx2 in atrial fibrillationR01HL118761 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI MARTIN, JAMES F · 2014 to 2025
$6.1M
Hippo and Wnt Signaling in Cardiac RegenerationR01HL127717 · NHLBI · TEXAS HEART INSTITUTE · PI MARTIN, JAMES F · 2016 to 2023
$4.4M
PPM1D in Clonal Hematopoiesis and MalignanciesR01CA237291 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARGARET A. GOODELL, Koichi Takahashi · 2019 to 2026
$3.7M
Mechanisms that regulate erythroid differentiation of hematopoietic stem cellsR01HL165145 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI NAKADA, DAISUKE · 2022 to 2025
$2.4M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
The Role of Histone Variant H3.3 Regulation by Hira in HematopoiesisF31DK112542 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MURDAUGH, REBECCA LAUREN · 2017 to 2020
$179k
Acetate as a Mediator of Hematopoietic Stem Cell Inflammatory Response and Clonal HematopoiesisF31HL164097 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI TIESSEN, JONATHAN · 2022 to 2025
$145k
NCI NIH HHS P01 CA265748NCI NIH HHS P30 CA125123NCI NIH HHS P50 CA100632NCI NIH HHS R01 CA237291NCRR NIH HHS S10 RR024574NHLBI NIH HHS F31 HL164097NHLBI NIH HHS R01 HL118761NHLBI NIH HHS R01 HL127717NHLBI NIH HHS R01 HL165145NHLBI NIH HHS T32 HL092332NIDDK NIH HHS F31 DK112542
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) are capable of regenerating the blood system, but the instructive cues that direct HSCs to regenerate particular lineages lost to the injury remain elusive. Here, we show that iron is increasingly taken up by HSCs during anemia and induces erythroid gene expression and regeneration in a Tet2-dependent manner. Lineage tracing of HSCs reveals that HSCs respond to hemolytic anemia by increasing erythroid output. The number of HSCs in the spleen, but not bone marrow, increases upon anemia and these HSCs exhibit enhanced proliferation, erythroid differentiation, iron uptake, and TET2 protein expression. Increased iron in HSCs promotes DNA demethylation and expression of erythroid genes. Suppressing iron uptake or TET2 expression impairs erythroid genes expression and erythroid differentiation of HSCs; iron supplementation, however, augments these processes. These results establish that the physiological level of iron taken up by HSCs has an instructive role in promoting erythroid-biased differentiation of HSCs.

Indexed as

AnemiaDioxygenasesCell DifferentiationDNA-Binding ProteinsErythroid CellsHematopoietic Stem CellsHumansIronSpleenDioxygenasesDNA-Binding ProteinsIronTET2 protein, human

Identifiers

PMID38225226
PMCPMC10789814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.